Essays about: "In vitro potency"

Showing result 1 - 5 of 6 essays containing the words In vitro potency.

  1. 1. Validation of a 3D culture model for toxicity studies in malignant and non-cancerous cells

    University essay from Lunds universitet/Institutionen för immunteknologi

    Author : Kajsa Andreasson Dahlgren; [2021]
    Keywords : Dose-response; potency; in vitro; 2D model; 3D model; cancer; MEK inhibitor; trametinib; A549; LL47; Western blot; Biology and Life Sciences;

    Abstract : Cancer is a widespread and commonly fatal disease in constant need of new treatments. Traditionally, new pharmaceuticals have been tested in 2D models. This is not ideal, as 2D environments do not reflect the in vivo milieu of the cells. READ MORE

  2. 2. Inhibition of different strains of Streptococcus mutans at different concentrations of Fluoride and Chlorhexidine

    University essay from Umeå universitet/Tandläkarutbildning

    Author : Christian Tutumlu; André Lund; [2021]
    Keywords : Streptococcus mutans; Fluoride; Chlorhexidine; SpaP A; SpaP B; SpaP C; Cnm Cbm.;

    Abstract : ABSTRACT Background: The most common species associated with dental caries is Streptococcus mutans. Different Streptococcus mutans adhesion biotypes, SpaP A/B/C and Cnm/Cbm, with ability to predict individual caries development have recently been identified. READ MORE

  3. 3. Dose-response for predicting skin sensitization potency with the GARD®skin method

    University essay from Lunds universitet/Institutionen för immunteknologi

    Author : Olivia Eliasson; [2019]
    Keywords : Dose-response; In vitro assay; GARD; skin sensitization; allergic contact dermatitis; chemical sensitizers; hazard assessment; skin sensitization potency; immunotoxicology; Technology and Engineering; Biology and Life Sciences;

    Abstract : Allergic contacts dermatitis is a major health problem in the world and the disease is caused by a type IV hypersensitivity to a small chemical called a hapten. These substances are common in cosmetics, perfumes, pharmaceuticals and house-hold products, and risk factors include both inherent factors and frequent or high exposure. READ MORE

  4. 4. In vitro potens i förhållande till terapeutisk plasmakoncentration för nio etablerade läkemedel

    University essay from SLU/Dept. of Biomedical Sciences and Veterinary Public Health

    Author : Melinda Johannesson; [2013]
    Keywords : In vitro potens; terapeutisk plasmakoncentration; etablerade läkemedel; läkemedelsutveckling; estimering; brister; In vitro potency; effective plasma concentration; marketed drugs; drug discovery process; prediction; flaws;

    Abstract : Antalet läkemedel som lanseras på marknaden har minskat under mer än ett decennium, vilket väcker frågan om huruvida det finns brister i de metoder och resonemang som används vid utvecklingen av ett nytt läkemedel. Syftet i den här litteraturstudien var att utreda delar av frågan kring eventuella brister med hjälp av följande frågeställningar: Vilka in vitro potenser kan man hitta vid en litteratursökning för några på marknaden etablerade humana och/eller veterinära läkemedelssubstanser? Hur förhåller sig in vitro potensen för dessa substanser till den terapeutiska plasmakoncentrationen/det terapeutiska intervallet som har fastställts för dem? Vad finns det i dagsläget för teorier kring eventuella brister i den rådande läkemedelsutvecklingsprocessen? In vitro potens-data för nio etablerade läkemedelssubstanser samlades in och jämfördes med respektive substans terapeutiska plasmakoncentration och en kvot erhölls som sedan relaterades till det resultat som presenterades i en mastersuppsats i farmaci av Fabian Göransson där motsvarande kvot genererades för 150 etablerade läkemedelssubstanser. READ MORE

  5. 5. Molecular topology, a novel descriptor for compound quality assessment

    University essay from Lunds universitet/Examensarbeten i bioinformatik

    Author : Rurika Oka; [2012]
    Keywords : Biology and Life Sciences;

    Abstract : Abstract The pharmaceutical industry is currently facing a high clinical attrition rate. In order to prevent the late-stage clinical failure, many investigations on compound quality and drug-likeness of compounds have been carried out. It has been widely accepted that molecular size and lipophilicity plays an important role in compound quality. READ MORE